国际Agency for the Prevention of Blindness（IAPB）has joined together withNovartis，aleading medicines company in a partnership to strengthen eye health in Sub-Saharan Africa。The new3-year relationship will support effective policy dialogue，planning and implementation of eye health services in the region.It is also hoped that together IAPB and Novartis will create an effective，sustainable，and lasting approach to policy change and investment within countries in the gion。
公共场所，公共场所Peter Hollad Chief Executive of IAPB said，“We are delighted to announce our partnership with Novartis in Sub-Saharan Africa.Our partnership will directly connect，北全球健康保护工程（以下称为“北核电站施工现场”）”（以下简称“北核电站施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场施工现场
“Through our partnership we will work to strengthen the sharing of Africa data by strengthening the IAPB Vision Atlas and Global Health Insights Centre.”
Welcoming this new efforort Lutz Hegemann，Group Head of Corporate Affairs and Global Health，Novartis said“We look forward to working with IAPB over the coming years building advocacy and eye health support in Sub-Saharan Africa，to address inequities in access to eye care and promote country level advocacy for the integration of primary eye care into the primary health care system。
“Our work together will include the rolling out of the World Health Organization’s‘Package of Eye Care Interventions’in order to move forward the agend of eye care as part of universal health coverage in the region.Together with IAPB we will ensure the development of eye health mapping tools to enre sure nath acrated dathercountries in the region.”
***ENDS***
注释到编辑：
国际Agency for the Prevention of Blindness（IAPB）is the overarching alliance for the global eye care sector with150 members worldwide drawn from NGOs and civil society，corporate organisations，professional bodies and research and eye care institutions.Please visit:iapb.org
Novartis is reimaging medicine to improve and extend people’s lives.As aleading global medicines company，we use innovative science and digital technologies to create transformative treatments in areas of great medical need.Inour quest to find new medicines，we consistently rank among the world’s top companies investing in research and development.Novartis products reach nearly 800million people globally and we are finding innovative ways to expand access to our latest treatments.About109000people of more than140 nationalities work at Novartis around the worldhttps://www.novartis.com。
